Listen to this episode on Apple Podcasts, Spotify, YouTube, or the Weill Cornell Medicine website.
Treatment for acute myeloid leukemia (AML), an aggressive blood cancer that affects the bone marrow and disrupts normal blood cell production, has advanced significantly over the past decade. On this episode of CancerCast, Dr. Manish Shah speaks with Dr. Gail Roboz, Director of the Clinical and Translational Leukemia Program at Weill Cornell Medicine and NewYork-Presbyterian, about the rapid pace of progress and advancement in AML therapy. They discuss insights into new all-oral treatment regimens, targeted therapies, molecular testing to improve the detection of cancer down to one in a million leukemia cells, and efforts to minimize side effects and expand treatment options for older patients and patients who may not be able to tolerate intensive chemotherapy. Dr. Roboz helped spearhead the all-oral regimen that was recently approved by the U.S. Food and Drug Administration (FDA), which combines decitabine and cedazuridine with venetoclax. She describes these practice-changing data and explains how lessons from treating acute promyelocytic leukemia (APL) are informing strategies to develop more precise, effective, and less toxic treatments for other AML subtypes. The conversation also examines the role of stem cell transplant in helping patients achieve and maintain remission after initial treatments clear the leukemia cells from the bone marrow and restore normal blood cell production, as well as the future of AML drug development to improve outcomes for patients.
Guest: Gail Roboz, MD, Director of the Clinical and Translational Leukemia Program at Weill Cornell Medicine and NewYork-Presbyterian Hospital
Host: Manish Shah, MD, Chief of Solid Tumor Service and Director of Gastrointestinal Oncology at Weill Cornell Medicine and NewYork-Presbyterian Hospital.
New scientific developments are transforming the future of cancer treatment and care. Hosted by world-renowned medical oncologist Dr. Manish Shah, CancerCast is your window into research breakthroughs, innovative therapies, and honest accounts of living with and beyond cancer.
Listen to all episodes or subscribe to the podcast on Apple Podcasts, YouTube, and Spotify. Questions or suggestions? Email us at cancercast@med.cornell.edu.